Market Tracker

03/31 8:22am ET

Immunomedics Inc (NASDAQ:IMMU)

3.89
Delayed Data
As of Mar 30
 +0.18 / +4.85%
Today’s Change
3.04
Today|||52-Week Range
5.48
-18.96%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.71
Today’s open3.74
Day’s range-- - --
Volume697,288
Average volume (3 months)1,027,378
Market cap$363.3M
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book9.20

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd+0.37+3.25%
ENTLEntellus Medical Inc+1.18+5.42%
ARDXArdelyx Inc-0.80-5.71%
CLDNCelladon Corp+0.58+2.75%
Data as of 03/30/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts